Fig. 5From: “Oil-soluble” reversed lipid nanoparticles for oral insulin deliveryResults of a in vitro release and b enzymatic stability of ORLN-PHI formulation at 37 °C in artificial intestinal fluid as the release medium (pH 6.5). PHI was measured using high-performance liquid chromatography. Data are represented as the mean ± SD (n = 3)Back to article page